Invest Before Med-X Planned Nasdaq Debut

A message from Med-x Inc.

Med-X is more than a natural pesticide company – it's a fast-growing player in the $17 billion pest control industry, and it's preparing for a major leap: a potential listing on the Nasdaq under the ticker MXRX. But here's the thing – your opportunity isn't after the bell rings. It's now. Founded with a mission to bring safer, plant-based alternatives to market, Med-X has already generated over $6.4 million in revenue in the last four years. Its flagship Nature-Cide product line has outperformed conventional chemical pesticides in independent tests for certain use cases and is trusted by pest control professionals and national retailers alike. Available today through ecommerce leaders Walmart, Amazon, and Kroger as well as extensive commercial distribution partnerships. Registered in Mexico, Singapore, Thailand and expanding internationally into 41+ markets. Formulated to meet growing demand for natural, eco-friendly pest control. Aligned with global sustainability and public health trends. While many startups are still in development mode, Med-X has real-world traction. Their products are trusted by professionals and being used in the field – used in commercial, residential, public health, aerial and organic food production applications. As climate change, regulation, and consumer demand continue pushing the pesticide industry toward natural solutions, Med-X stands positioned as a category leader with an active customer base and scalable manufacturing. What makes this moment unique? The company is preparing for a Nasdaq direct listing – and shares are currently available at $4.00 through a Regulation A+ offering. Med-X is targeting a clean, repeat-revenue business model that sits at the intersection of sustainability, public health, and scalable consumer retail. [Review the full Med-X investment opportunity] This is a company already solving real problems, with real customers, and a clear path to expansion. Don't wait until the direct listing headlines hit. Look closer now. Disclosures This is a paid advertisement for Med-X's Regulation A+ Offering. Please read the offering circular at invest.medx-rx.com.

This is a paid advertisement provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not necessarily endorse this product nor is it responsible for the content of this advertisement. Schaeffer's makes no guarantee or warranty about what is advertised above. To stop receiving these emails, unsubscribe. Schaeffer's Investment Research 5151 Pfeiffer Road, Suite 450 Cincinnati, Ohio 45242